AVTR News

After a busy week in the IPO market, just one biotech is scheduled to go public in the week ahead. NASH biotech 89bio (ETNB) plans to raise $85 million at a $225 million market cap. The company’s target indication represents a multi-billion-dollar market with no FDA-approved therapy; consequently, there are ...read more

After the busiest week of the year in the prior week, May 2019 continued to be active this past week with five IPOs and one SPAC offering. Three came to market with valuations of more than $1 billion, including fast-growing unicorns Luckin Coffee and Fastly, and Avantor, the largest IPO of an LBO'd company since 2011. Avantor (AVTR), an LBO'd...read more

Avantor, a LBO'd distributor and manufacturer of laboratory supplies and services, raised $2.9 billion by offering 207 million shares at $14, the low end of the revised range of $14 to $15. Avantor originally filed to raise $3.0 billion by offering 154 million shares at a range of $18 to $20. In addition, the company raised $900 million by offering 18 million mandatory convertible...read more

Avantor, an LBO'd distributor and manufacturer of laboratory supplies and services, lowered the proposed range and increased the share offering for its upcoming IPO on Thursday. The Radnor, PA-based company now plans to raise $3.0 billion by offering 205 million shares at a price range of $14 to $15. The company had previously filed to raise roughly the same amount by offering...read more